Health
FDA approves rapid influenza test
NEWS IN BRIEF — Posted April 27, 2009
The Food and Drug Administration approved a new, more rapid test for the detection of influenza A/H5N1, the subtype that can cause serious illness in humans and that has been considered a possible candidate to trigger a pandemic.
The test, approved on April 7, can identify in less than 40 minutes a specific protein that indicates the presence of the viral subtype. Previous tests took three to four hours to produce results.
"This test is an important tool to help quickly identify emerging influenza A/H5N1 infections and reduce exposure to large populations," said Daniel G. Schultz, MD, director of the FDA's Center for Devices and Radiological Health. "The clearance of this test represents a major step toward protecting the public from the threat of pandemic flu."
As of early April, there have been 412 confirmed human cases from this virus, almost all in Asia and northern Africa.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2009/04/27/hlbf0427.htm.












